
Syed Rahamthulla
About Syed Rahamthulla
Data last updated:
Syed Rahamthulla is a Director at Pathgene Health Care Private Limited (since 2015), Director at Sequragen Labs Private Limited (since 2026) and Director at Bioquantica Biotech Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Healthcare, Infrastructure and Utilities and Chemicals. The largest current company by reported revenue is Pathgene Health Care Private Limited at ₹5.88 Cr (FY 2021). Earlier, Syed Rahamthulla was a Director at Urantiis Pharmaceuticals Private Limited (2022–2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 23 Apr 2015 | 2015 | ₹5.88 Cr (FY 2021) | Active | |
| Director | 27 Aug 2026 | 2026 | Active | ||
| Director | 11 Nov 2025 | 2025 | Active | ||
| Nominee Director | 12 May 2023 | 2020 | Active | ||
| Director | 14 Jul 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Jun 2022 | 2022 | ₹3.73 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Syed Rahamthulla
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Syed Rahamthulla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Syed Rahamthulla
Syed Rahamthulla currently holds 5 directorships: Pathgene Health Care Private Limited (Director, since 23 Apr 2015, revenue βΉ5.88 Cr (FY 2021)); Sequragen Labs Private Limited (Director, since 27 Aug 2026); Bioquantica Biotech Private Limited (Director, since 11 Nov 2025); Tirupati Electronics Manufacturing Cluster Limited (Nominee Director, since 12 May 2023); Toxgene Ar Biolabs Private Limited (Director, since 14 Jul 2022).
Syed Rahamthulla was first appointed on 23 Apr 2015 as Director at Pathgene Health Care Private Limited. The most recent appointment on record is 27 Aug 2026 at Sequragen Labs Private Limited.
Syed Rahamthulla held 1 earlier board appointment: Urantiis Pharmaceuticals Private Limited (Director, 06 Jun 2022 to 01 Mar 2025).
The current boards of Syed Rahamthulla's companies include Ramireddy Nageswari (Pathgene Health Care Private Limited), Sateesh Maddirevula (Sequragen Labs Private Limited), Sultana Sufia (Sequragen Labs Private Limited), Nitin Kumar Semwal (Bioquantica Biotech Private Limited), Ayyappa Basani (Tirupati Electronics Manufacturing Cluster Limited), Chandra Sekhar . Jangam (Tirupati Electronics Manufacturing Cluster Limited), among others.